HomeCompareSBXC vs JNJ

SBXC vs JNJ: Dividend Comparison 2026

SBXC yields 18.45% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBXC wins by $46.3K in total portfolio value
10 years
SBXC
SBXC
● Live price
18.45%
Share price
$10.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$66.4K
Annual income
$5,691.06
Full SBXC calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SBXC vs JNJ

📍 SBXC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSBXCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SBXC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SBXC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBXC
Annual income on $10K today (after 15% tax)
$1,568.27/yr
After 10yr DRIP, annual income (after tax)
$4,837.40/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SBXC beats the other by $4,133.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBXC + JNJ for your $10,000?

SBXC: 50%JNJ: 50%
100% JNJ50/50100% SBXC
Portfolio after 10yr
$43.2K
Annual income
$3,259.42/yr
Blended yield
7.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SBXC
No analyst data
Altman Z
6.7
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBXC buys
0
JNJ buys
0
No recent congressional trades found for SBXC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSBXCJNJ
Forward yield18.45%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$66.4K$20.0K
Annual income after 10y$5,691.06$827.78
Total dividends collected$36.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SBXC vs JNJ ($10,000, DRIP)

YearSBXC PortfolioSBXC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,545$1,845.02$10,676$355.77+$1.9KSBXC
2$15,586$2,163.16$11,407$389.39+$4.2KSBXC
3$19,189$2,511.75$12,198$426.53+$7.0KSBXC
4$23,422$2,890.04$13,056$467.62+$10.4KSBXC
5$28,359$3,296.83$13,987$513.12+$14.4KSBXC
6$34,074$3,730.52$14,998$563.56+$19.1KSBXC
7$40,649$4,189.16$16,098$619.52+$24.6KSBXC
8$48,165$4,670.49$17,295$681.69+$30.9KSBXC
9$56,708$5,172.01$18,599$750.82+$38.1KSBXC
10$66,369$5,691.06$20,022$827.78+$46.3KSBXC

SBXC vs JNJ: Complete Analysis 2026

SBXCStock

SilverBox Corp III focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on businesses in the consumer, food and agriculture, e-commerce, Internet and retail, financial services, financial technology, media, entertainment and hospitality, business services, software and SaaS, telecommunications services and technology, industrial technology , and infrastructure and energy transition sectors. The company was incorporated in 2021 and is based in Austin, Texas.

Full SBXC Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SBXC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBXC vs SCHDSBXC vs JEPISBXC vs OSBXC vs KOSBXC vs MAINSBXC vs ABBVSBXC vs MRKSBXC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.